Skip to main content
Equibles

ALIVUS · Alivus Life Sciences Limited

Use ALIVUS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ALIVUS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
1,460.60 INR +16.90 (+1.17%) At close · Nov 13
Rebalance outlook locked
Market Cap
179.32B INR
Shares
122.77M
Volume · Nov 13 600.13K Avg daily vol (3M) 242.47K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close1,460.60 INR Open1,443.70 INR Day1,443.70–1,499.90 INR 52W close860.05–1,558.70 INR Avg vol 30d329K Last earningsOct 30, 2026 DataAug 2021–Nov 2026

Latest documents

2026
Oct 30
Earnings call
Q2 FY27 revenue rises 16% as guidance is reiterated

Alivus Life Sciences Limited reported Q2 FY27 revenue of Rs. 682 crores, up 16% year-on-year, and reiterated FY27 revenue growth guidance of 10-12% and EBITDA margin guidance of 35-36%.

3 source passages
For Q2 FY27, revenue from operations stood at Rs. 682, a growth of 16% year-on-year. So, accordingly, we reiterate our FY27 revenue growth guidance of 10-12%. We are confident of delivering EBITDA margins in the 35-36% range in FY27. Open the document at this passage
All documents

Quarterly results

Revenue Net income Net loss
▲12.1% 6.42B INR 1.37B INR '25 Q3 ▲21% 6.50B INR 1.42B INR '25 Q4 ▲2.2% 6.02B INR 1.22B INR '26 Q1 ▲16% 5.88B INR 1.30B INR '26 Q2 ▲4.8% 6.73B INR 1.50B INR '26 Q3 ▲6.1% 6.89B INR 1.63B INR '26 Q4 ▲6.4% 6.40B INR 1.60B INR '27 Q1 LATEST ▲16% 6.82B INR 1.97B INR '27 Q2

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 860.05 INR Now 1,460.60 INR · 86% Range high 1,558.70 INR
vs 200-day avg +27% vs 50-day avg +6%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

5D 20D 120D MTD YTD
XNSE:ALIVUS -1.4% +8.9% +40.6% +3.2% +59.4%

Exchange listing

Market
XNSE
Ticker
ALIVUS
ISIN
INE03Q201024
Security
Ordinary share
Trading currency
INR

Company

Website
https://www.alivus.com/
Investor relations
https://www.alivus.com/disclosures-as-per-regulation-46-of-sebi-lodr-2015/

Other listings of this company

Share classes and depositary receipts can have different prices and dividends.

Recent dividends

Ex-dividend dateAmount per share
2026-09-01 5.00 INR
2025-09-01 5.00 INR
2023-10-17 22.50 INR
2023-03-24 21.00 INR
2022-09-15 10.50 INR
2021-11-22 10.50 INR

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

  • Earnings call · Q2 2027 2026-10-30 Audio Transcript
    Earnings Call
  • Earnings call · Q1 2027 2026-07-31 Audio Transcript
    Earnings Call for the Quarter Ended June 30, 2026
  • Earnings call · Q4 2026 2026-05-15 Audio Transcript
    Earnings Call for the Quarter Ended March 31, 2026